The Sarah Cannon Research Institute-Pharmacy — Nashville, Tennessee

The Sarah Cannon Research Institute-Pharmacy is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

The Sarah Cannon Research Institute-Pharmacy has participated in 1 clinical trials.

Therapeutic areas: HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Sarah Cannon Research Institute-Pharmacy?

The Sarah Cannon Research Institute-Pharmacy has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Sarah Cannon Research Institute-Pharmacy conducted?

The Sarah Cannon Research Institute-Pharmacy has 1 clinical trials on record. Their work covers HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer.

Is The Sarah Cannon Research Institute-Pharmacy accredited by Crixeo Health?

The Sarah Cannon Research Institute-Pharmacy has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Sarah Cannon Research Institute-Pharmacy?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.